European Archives - Page 782 of 899 - European Medical Journal

Continue
EMJ
4 Mins
15th April 2016

Celyad Will Present Its NKR-2 Immuno-Oncology Clinical Program at 2016 ASCO Annual Meeting

Mont-Saint-Guibert, Belgium: Celyad (Euronext Brussels and Paris, and NASDAQ: CYAD), a leader in the discovery and development of engineered cell…
EMJ
5 Mins
15th April 2016

Patients with EGFR Expressing Non-Small-Cell Lung Cancer Benefit Most from Necitumumab Added to Chemotherapy

GENEVA, Switzerland, 15 April 2016: Patients with epidermal growth factor receptor (EGFR) expressing advanced squamous non-small-cell lung cancer benefit…
EMJ
4 Mins
15th April 2016

Immunotherapy with Live Bacterium Improves Response Rate in Malignant Pleural Mesothelioma

GENEVA, Switzerland, 14 April 2016: Immunotherapy with a live bacterium combined with chemotherapy demonstrated more than 90% disease control and…
EMJ
7 Mins
15th April 2016

Osimertinib given as First-Line Treatment May Alter Biology of EGFR Mutated Non-Small-Cell Lung Cancer

GENEVA, Switzerland, 14 April 2016 – The third generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) osimertinib is…
EMJ
1 Mins
15th April 2016

Richard Wolf Launches a New ENDOCAM Flex HD Video Solution

Knittlingen, 13 April 2016: Manufacturer of medical products Richard Wolf is launching the new “ENDOCAM Flex HD” video solution on 1 March 2016.
EMJ
12th April 2016

Discussion on mild and moderate IBD treatment led by Prof Geert D’Haens

Took place during the 11th Congress of ECCO.
EMJ
12th April 2016

Success factors in the treatment of uncomplicated CD by Dr Pieter Hindryckx

Took place during the 11th Congress of ECCO. Dr Pieter Hindryckx, Department of Gastroenterology, University Hospital of Ghent, Ghent, Belgium considers…
EMJ
12th April 2016

Success factors in the treatment of mild-to-moderate UC by Dr Ailsa Hart

Took place during the 11th Congress of ECCO. During this symposium Dr Ailsa Hart, Director, IBD Unit, St Mark’s Hospital, London, UK discusses the…
EMJ
2 Mins
12th April 2016

Helsinn Supports the Development of NCCN Guidelines for Patients® on Nausea and Vomiting, with a Sponsorship Grant

Lugano, Switzerland, April 11, 2016: Helsinn, the Swiss pharmaceutical Group focused on building quality cancer care, announces that it is supporting…
EMJ
3 Mins
12th April 2016

Heine H. Hansen Award Goes to Suresh Senan

Geneva, Switzerland, 11 April: The European Society for Medical Oncology (ESMO) and the International Association for the Study of Lung Cancer (IASLC)…